Embryonic stem cells go from bench to bedside for Parkinson’s disease
oleh: Clare L. Parish, Lachlan H. Thompson
| Format: | Article |
|---|---|
| Diterbitkan: | Elsevier 2021-04-01 |
Deskripsi
Stem-cell-derived transplants may soon be a promising treatment option for Parkinson’s disease. In preparation for clinical trial, Piao et al.1 report on generating a clinical-grade dopaminergic progenitor cell product and its rigorous testing to ensure safety and efficacy.